Medication info

Albis Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Lightpharmtech Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201901862 · Approved 2019.03.28

This product's status changed to Expired on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of ulcers and acid-related disorders (such as gastritis and reflux esophagitis), and prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily, or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for preventing gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks, or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily; the dose may be increased if necessary. In severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Ingredients

Manufacturer
Lightpharmtech Co., Ltd.

Efficacy & effects

Treatment of ulcers and acid-related disorders (such as gastritis and reflux esophagitis), and prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcer
  • NSAID-induced gastric ulcer
  • NSAID-induced duodenal ulcer.
View approved original text

This medication is used for various gastrointestinal diseases including gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and helps prevent ulcers post-surgery. It is used for the treatment of gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs). This medication effectively aids in improving a range of gastrointestinal conditions.

How to take

Adult dose

○ Adults Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily, or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for preventing gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks, or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily; the dose may be increased if necessary. In severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Precautions

This medication should not be used by patients undergoing dialysis. Individuals who have had allergic reactions to this drug or any of its components should not use it. Patients with a history of a rare disease called acute porphyria should not be administered this drug as it may worsen symptoms. Patients with impaired kidney function or kidney disorders should not use this drug. Patients who have undergone upper gastrointestinal surgery should preferably avoid taking this drug. Women who are pregnant or may become pregnant should not take this drug. It has not been established as safe for premature infants or newborns, so it is not administered to them. Patients on dietary restrictions that limit potassium intake should not use this drug. Patients with liver dysfunction should use this drug cautiously, and those with a history of drug allergies should also exercise caution. Elderly patients or those with a history of kidney disorders should also be careful when using this drug. If taken in conjunction with NSAIDs, particularly in the elderly or those with a history of peptic ulcers, it is important to have regular check-ups. This medication may mask symptoms of gastric cancer, so gastric ulcer patients or middle-aged patients with newly developed dyspeptic symptoms should confirm they do not have a malignant condition before using it. Patients with gastric or duodenal ulcers caused by Helicobacter pylori infection should receive simultaneous treatment to eradicate the bacteria. In severely ill patients in intensive care, there may be a risk of developing a gastric stone, so caution is advised. Patients with hypophosphatemia should be aware that the components of this medication may interfere with phosphate absorption. Patients with swallowing difficulties have reported respiratory complications after administration of this drug, so they should be cautious. During treatment with this drug, there is a rare possibility of experiencing allergic reactions or shock; if symptoms occur, treatment should be stopped immediately and medical attention sought. Blood tests may reveal abnormalities like leukopenia or thrombocytopenia. If there are changes in physical condition, immediate testing is advised. Liver function abnormalities may occur, so if symptoms of hepatitis or jaundice appear, medication should be discontinued immediately. Circulatory system abnormalities such as arrhythmias or vasculitis may occur rarely, so vigilance is needed. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain. CNS symptoms such as dizziness, drowsiness, confusion, seizures, and insomnia may occur rarely, so if unusual symptoms appear, consultation with a healthcare provider is necessary. Myalgia or arthralgia, and in rare cases symptoms of muscle damage may occur, so treatment should be stopped if symptoms are severe. Dermatological reactions, such as skin rash or hair loss, have also been reported rarely. It is important to avoid long-term use, and during treatment, regular monitoring of blood, liver, and kidney function is crucial. If dizziness or drowsiness occurs while taking this medication, driving and operating dangerous machinery should be avoided. There may be interactions with other medications, so it is essential to inform your healthcare provider of any other drugs being taken. Women who are pregnant or breastfeeding should not take this medication, and its safety for children has not been established, so its use is not recommended. In case of overdose, emergency treatments like vomiting or gastric lavage may be necessary, so caution is advised.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 62 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • increased AST
  • increased ALT
  • elevated r-GTP
  • increased ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • decreased appetite
  • dizziness
  • drowsiness
  • altered mental status
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hypertensive muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • blackening of the tongue
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1°C and 30°C. Storing it this way will help maintain its efficacy for a longer period.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.